| LP448966-4 | Epinephrine induced.6 umol/L | METHOD | |
| LP448967-2 | Reptilase time.factor substitution immediately after addition of normal plasma | METHOD | 1 |
| LP448968-0 | US.fibrinogen contribution.tissue factor induced and platelet glycoprotein IIb-IIIa receptor inhibited | METHOD | |
| LP448969-8 | Microviscometry.glass bead induced | METHOD | 3 |
| LP448971-4 | Kaolin induced | METHOD | |
| LP448972-2 | Thromboelastography.kaolin induced.30M after maximum clot amplitude after addition of heparinase | METHOD | 1 |
| LP448973-0 | Kaolin induced.after addition of heparinase | METHOD | |
| LP448974-8 | Thromboelastography.kaolin induced.after addition of heparinase | METHOD | 4 |
| LP448975-5 | Thromboelastography.resonance.kaolin induced.after addition of heparinase | METHOD | 1 |
| LP448977-1 | Microviscometry.kaolin induced | METHOD | 2 |
| LP448978-9 | Thromboelastography.kaolin induced | METHOD | 4 |
| LP448979-7 | Thromboelastography.resonance.kaolin induced | METHOD | 5 |
| LP448980-5 | US.kaolin induced | METHOD | 1 |
| LP448981-3 | Kaolin.tissue factor induced | METHOD | |
| LP448982-1 | Thromboelastography.resonance.kaolin.tissue factor induced | METHOD | 1 |
| LP448983-9 | Norepinephrine induced | METHOD | |
| LP448986-2 | Prostaglandin induced | METHOD | |
| LP448987-0 | Reptilase time | METHOD | 3 |
| LP448988-8 | Induced by Ristocetin | METHOD | 1 |
| LP448989-6 | Ristocetin induced.1.0 mg/mL | METHOD | |
| LP448990-4 | Ristocetin induced.1.25 mg/mL | METHOD | |
| LP448991-2 | Ristocetin induced.1000 mg/L | METHOD | 1 |
| LP448992-0 | Ristocetin induced.1000 ug/mL | METHOD | |
| LP448993-8 | Ristocetin induced.1125 mg/L | METHOD | 1 |
| LP448994-6 | Ristocetin induced.1200 ug/mL | METHOD | |
| LP448995-3 | Ristocetin induced.125 ug/mL | METHOD | |
| LP448996-1 | Ristocetin induced.15 ug/mL | METHOD | |
| LP448997-9 | Ristocetin induced.1500 ug/mL | METHOD | |
| LP448998-7 | Ristocetin induced.1800 ug/mL | METHOD | |
| LP448999-5 | Ristocetin induced.250 ug/mL | METHOD | |
| LP449000-1 | Ristocetin induced.300 ug/mL | METHOD | |
| LP449001-9 | Ristocetin induced.375 ug/mL | METHOD | |
| LP449002-7 | Ristocetin induced.5 ug/mL | METHOD | |
| LP449003-5 | Ristocetin induced.500 mg/L | METHOD | 1 |
| LP449004-3 | Ristocetin induced.500 ug/mL | METHOD | |
| LP449005-0 | Ristocetin induced.600 ug/mL | METHOD | |
| LP449006-8 | Ristocetin induced.750 ug/mL | METHOD | |
| LP449007-6 | Ristocetin induced.800 ug/mL | METHOD | |
| LP449008-4 | Ristocetin induced.900 ug/mL | METHOD | |
| LP449009-2 | Ristocetin induced.high dose | METHOD | |
| LP449010-0 | Ristocetin induced.low dose | METHOD | |
| LP449011-8 | Ristocetin+Control PPP induced | METHOD | |
| LP449012-6 | Ristocetin+Control PRP induced | METHOD | |
| LP449015-9 | Surface induced circulating inhibitor | METHOD | |
| LP449016-7 | aPTT.factor substitution 1H post incubation with 1:4 normal plasma | METHOD | 1 |
| LP449017-5 | aPTT 1 hour post incubation | METHOD | 1 |
| LP449018-3 | aPTT.factor substitution 2H post incubation with 1:4 normal plasma | METHOD | 1 |
| LP449019-1 | aPTT after addition of APC | METHOD | 1 |
| LP449020-9 | Coag.surface induced.after addition of protein C activator | METHOD | 1 |
| LP449021-7 | Coagulation surface induced.factor sensitive with 1:1 Pooled Normal Plasma | METHOD | 1 |